Literature DB >> 32933793

A "Tail" of Immunotherapy in Metastatic Prostate Cancer.

Russell K Pachynski1.   

Abstract

Entities:  

Year:  2020        PMID： 32933793     DOI： 10.1016/j.eururo.2020.08.040

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  3 in total

Review 1.  Immune Checkpoint Inhibitors: A Promising Treatment Option for Metastatic Castration-Resistant Prostate Cancer?

Authors:  Vicenç Ruiz de Porras; Juan Carlos Pardo; Lucia Notario; Olatz Etxaniz; Albert Font
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

2.  IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC).

Authors:  Russell K Pachynski; Chihiro Morishima; Russell Szmulewitz; Lauren Harshman; Leonard Appleman; Paul Monk; Rhonda L Bitting; Omer Kucuk; Frederick Millard; John D Seigne; Steven P Fling; Holden T Maecker; Caroline Duault; Nirasha Ramchurren; Bruce Hess; Leonard D'Amico; Andreanne Lacroix; Judith C Kaiser; Michel Morre; Anne Grégoire; Martin Cheever; Evan Y Yu; Lawrence Fong
Journal:  J Immunother Cancer       Date:  2021-08       Impact factor: 13.751

3.  Integrated Analysis of the Transcriptome Profile Reveals the Potential Roles Played by Long Noncoding RNAs in Immunotherapy for Sarcoma.

Authors:  Boran Pang; Yongqiang Hao
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.